Literature DB >> 33127325

Successful Long-Term Ibrutinib Treatment in a Hemodialysis Patient With Leukemic Nonnodal Mantle Cell Lymphoma.

Hajime Yasuda1, Yutaka Tsukune2, Tadaaki Inano2, Yosuke Mori2, Yasunori Ota3, Norio Komatsu2.   

Abstract

Entities:  

Keywords:  BTK inhibitor; Dialysis; Renal failure; Renal replacement therapy; Safety

Mesh：

Substances：

Year:  2020        PMID： 33127325     DOI： 10.1016/j.clml.2020.10.007

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  3 in total

1.  Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.

Authors:  Hajime Yasuda; Mutsuko Yasuda; Norio Komatsu
Journal:  Cancer Sci       Date:  2021-06-11       Impact factor: 6.716

2.  Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib.

Authors:  Hajime Yasuda; Yuji Tomizawa; Sakiko Harada; Makoto Sasaki; Norio Komatsu; Jun Ando; Nobutaka Hattori; Miki Ando
Journal:  Heliyon       Date:  2022-10-05

3.  Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib.

Authors:  Yasunobu Sekiguchi; You Nishimura; Hiroaki Kanda; Machiko Kawamura; Kazuhiko Kobayashi; Hirofumi Kobayashi
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.